Characteristics | No. | OS | Â | Â | RFS | Â | Â |
---|---|---|---|---|---|---|---|
 |  | HR | 95% CI | P | HR | 95% CI | P |
Age, y, ≥ 50 (vs. < 50) | 41/145 | 2.928 | 1.620-5.293 | < 0.001 | 1.914 | 1.112-3.295 | 0.019 |
TNM stage, I | 29/145 | 1 | Â | 0.016 | 1 | Â | 0.197 |
        II | 97/145 | 2.482 | 0.874-7.046 | 0.088 | 1.386 | 0.644-2.983 | 0.403 |
      III and IV | 19/145 | 5.154 | 1.614-16.457 | 0.006 | 2.288 | 0.902-5.799 | 0.081 |
Histologic grade, 1 | 49/145 | 1 | Â | 0.014 | 1 | Â | 0.087 |
        2 | 67/145 | 1.218 | 0.575-2.579 | 0.607 | 1.147 | 0.598-2.198 | 0.680 |
        3 | 29/145 | 2.818 | 1.293-6.139 | 0.009 | 2.077 | 1.027-4.203 | 0.042 |
HER2, positive (vs. negative) | 40/145 | 2.765 | 1.525-5.012 | < 0.001 | 2.596 | 1.511-4.461 | < 0.001 |
ER, positive (vs. negative) | 80/145 | 0.691 | 0.382-1.250 | 0.222 | 0.911 | 0.533-1.557 | 0.733 |
NGF, positive (vs. negative) | 45/145 | 4.674 | 2.541-8.598 | < 0.001 | 3.55 | 2.074-6.076 | < 0.001 |
HO1, positive (vs. negative) | 71/145 | 6.101 | 2.832-13.143 | < 0.001 | 3.476 | 1.914-6.314 | < 0.001 |
NGF/HO1, NGF-/HO1- | 69/145 | 1 | Â | < 0.001 | 1 | Â | < 0.001 |
      NGF-/HO1+ | 31/145 | 5.019 | 1.855-13.578 | 0.001 | 2.935 | 1.338-6.436 | 0.007 |
      NGF+/anyHO1 | 45/145 | 9.717 | 4.003-23.586 | < 0.001 | 5.41 | 2.754-10.625 | < 0.001 |